Your browser doesn't support javascript.
loading
Trends in prevalence of depression and anxiety symptoms and effects of sociodemographic variables before and after the first wave of COVID-19 in Qatar.
Khaled, Salma M; Davis, Veena; Amro, Iman; Ali, Amal A M; Woodruff, Peter W; Haddad, Peter M.
Afiliação
  • Khaled SM; Social and Economic Survey Research Institute-SESRI, Qatar University, Doha, P.O. Box: 2713, Qatar; Department of Public Health, College of Health Sciences, Qatar University, Doha, P.O. Box 2713, Qatar; Department of Population Medicine, College of Medicine, Qatar University, Doha, P.O. Box 2713, Qa
  • Davis V; Social and Economic Survey Research Institute-SESRI, Qatar University, Doha, P.O. Box: 2713, Qatar. Electronic address: veenadavis1@gmail.com.
  • Amro I; Social and Economic Survey Research Institute-SESRI, Qatar University, Doha, P.O. Box: 2713, Qatar. Electronic address: iman.amro@qu.edu.qa.
  • Ali AAM; Social and Economic Survey Research Institute-SESRI, Qatar University, Doha, P.O. Box: 2713, Qatar. Electronic address: amal.ali@qu.edu.qa.
  • Woodruff PW; Department of Neuroscience, School of Medicine, The University of Sheffield Western Bank, Sheffield S10 2TN, United Kingdom. Electronic address: p.w.woodruff@sheffield.ac.uk.
  • Haddad PM; Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar; College of Medicine, Qatar University, Qatar; Division of Psychology and Mental Health, University of Manchester, United Kingdom. Electronic address: phaddad@hamad.qa.
J Affect Disord ; 310: 412-421, 2022 08 01.
Article em En | MEDLINE | ID: mdl-35413356
BACKGROUND: Prevalence trends from Arabic speaking countries on psychiatric symptoms before and after the first wave of the COVID-19 pandemic are lacking. We estimated the point prevalence and change in depression and anxiety symptoms scores in relation to sociodemographic variables following the resolution of the first wave in Qatar compared with before the pandemic. METHODS: We conducted a trend analysis using repeated nationally representative cross-sectional surveys spanning 2017, 2018, 2020/2021 and using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) to assess depressive and anxiety symptoms. Negative binomial regression was used to model changes in these symptoms in relation sociodemographics and survey year. RESULTS: The two-week prevalence of depressive symptoms (≥10 on the PHQ-9) was 6.6% in 2017 and 6.5% in 2020/2021 (p = 0.986). The two-week prevalence of anxiety symptoms (≥10 on the GAD-7) was 3.6% in 2018 and 5.1% in 2020/2021 (p = 0.062). The data for 2020/21 showed a 35.1% and 29.2% decrease in depression and anxiety symptoms scores compared to pre-pandemic years (2017/2018) after adjusting for sociodemographic factors. LIMITATIONS: Screening tools rather than structured interviews were used to assess depressive and anxiety symptoms CONCLUSIONS: The prevalence of depression and anxiety after the first COVID wave did not differ significantly to pre-pandemic estimates. The end of the first wave of the pandemic weakened the associations of these symptoms with traditional sociodemographic risk factors. The 2020/21 depression and anxiety symptoms scores remained high for Qataris and Arabs, suggesting that these cultural groups may benefit most from public mental health interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article